TRxADE Health Inc. Continues to Lead the Pharmaceutical Industry with its Subsidiary, TRxADE Inc., Adding More Members in Q3 2023
TRxADE Health, Inc. affirms its commitment to the pharmaceutical space via its subsidiary Trxade, Inc. TAMPA, FL, Oct. 17, 2023 (GLOBE NEWSWIRE) — TRxADE HEALTH, INC. (NASDAQ: MEDS) TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE”), a parent company of pharmaceutical business-to-business exchange platform, which recently merged with Superlatus, Inc. (“Superlatus”), today reconfirms its commitment to the…